OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of enteric glia and microbiota-gut-brain axis in parkinson disease pathogenesis
Júlio César Claudino dos Santos, Micael Porto Portela Lima, Gerly Anne de Castro Brito, et al.
Ageing Research Reviews (2022) Vol. 84, pp. 101812-101812
Closed Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

The metabolites of lactic acid bacteria: classification, biosynthesis and modulation of gut microbiota
Huang Tang, Wanqiu Huang, Yu‐Feng Yao
Microbial Cell (2023) Vol. 10, Iss. 3, pp. 49-62
Open Access | Times Cited: 55

Gastrodia elata polysaccharide alleviates Parkinson's disease via inhibiting apoptotic and inflammatory signaling pathways and modulating the gut microbiota
Qingxia Gan, Maoyao Peng, Haobo Wei, et al.
Food & Function (2024) Vol. 15, Iss. 6, pp. 2920-2938
Closed Access | Times Cited: 18

From the Gut to the Brain: The Role of Enteric Glial Cells and Their Involvement in the Pathogenesis of Parkinson’s Disease
Alba Montalbán-Rodríguez, Raquel Abalo, Laura López‐Gómez
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1294-1294
Open Access | Times Cited: 16

The Interaction between Mushroom Polysaccharides and Gut Microbiota and Their Effect on Human Health: A Review
Jiahui Zhao, Yixin Hu, Chao Qian, et al.
Biology (2023) Vol. 12, Iss. 1, pp. 122-122
Open Access | Times Cited: 37

Gut-microbiome-brain axis: the crosstalk between the vagus nerve, alpha-synuclein and the brain in Parkinson’s disease
Júlio César Claudino dos Santos, Leandro Freitas Oliveira, Felipe Micelli Noleto, et al.
Neural Regeneration Research (2023) Vol. 18, Iss. 12, pp. 2611-2614
Open Access | Times Cited: 34

Nicotinic Acetylcholine Receptors in Glial Cells as Molecular Target for Parkinson’s Disease
Érica Novaes Soares, Ana Carla dos Santos Costa, Gabriel de Jesus Ferrolho, et al.
Cells (2024) Vol. 13, Iss. 6, pp. 474-474
Open Access | Times Cited: 10

Blood-brain barrier biomarkers
Juan F. Zapata-Acevedo, Alejandra Mantilla-Galindo, Karina Vargas-Sánchez, et al.
Advances in clinical chemistry (2024), pp. 1-88
Closed Access | Times Cited: 9

Gut mucosal cells transfer α-synuclein to the vagus nerve
Rashmi Chandra, Arpine Sokratian, Katherine Ramos Chavez, et al.
JCI Insight (2023) Vol. 8, Iss. 23
Open Access | Times Cited: 21

The gut microbes in inflammatory bowel disease: Future novel target option for pharmacotherapy
Shuo Yuan, Ke-Si Wang, Huan Meng, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 114893-114893
Open Access | Times Cited: 20

Unveiling the role of gut-brain axis in regulating neurodegenerative diseases: A comprehensive review
Himanshi Yadav, Jaldhi, Rati Bhardwaj, et al.
Life Sciences (2023) Vol. 330, pp. 122022-122022
Closed Access | Times Cited: 19

Advances in gut–brain organ chips
Yu Zhang, Siming Lu, Jianjian Zhuang, et al.
Cell Proliferation (2024) Vol. 57, Iss. 9
Open Access | Times Cited: 7

Nicotinic Acetylcholine Receptors in Glial Cells as Molecular Target for Parkinson’s Disease
Érica Novaes Soares, Ana Carla dos Santos Costa, Gabriel de Jesus Ferrolho, et al.
(2024)
Open Access | Times Cited: 5

Small molecule modulators of Alpha-Synuclein Aggregation and Toxicity: Pioneering an Emerging Arsenal Against Parkinson’s Disease
Ishfaq Ahmad Ahanger, Tanveer Ali Dar
Ageing Research Reviews (2024) Vol. 101, pp. 102538-102538
Closed Access | Times Cited: 5

The Interaction Between Nutraceuticals and Gut Microbiota: a Novel Therapeutic Approach to Prevent and Treatment Parkinson’s Disease
Liyan Yao, Yong Yang, Xiaowei Yang, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 11, pp. 9078-9109
Closed Access | Times Cited: 4

Efficacy of probiotic supplements on Parkinson's disease: A systematic review and meta-analysis
Xiaxia Jin, Wendi Dong, Kaile Chang, et al.
Complementary Therapies in Medicine (2024) Vol. 82, pp. 103045-103045
Open Access | Times Cited: 4

Intermittent Metabolic Switching and Vascular Cognitive Impairment
Vismitha Rajeev, Nishat I. Tabassum, David Y. Fann, et al.
Journal of Obesity & Metabolic Syndrome (2024) Vol. 33, Iss. 2, pp. 92-107
Open Access | Times Cited: 4

Irisin's emerging role in Parkinson's disease research: A review from molecular mechanisms to therapeutic prospects
Ruqing Qiu, Weilu Sun, Yana Su, et al.
Life Sciences (2024) Vol. 357, pp. 123088-123088
Closed Access | Times Cited: 4

Pannexin-1 regulation of ATP release promotes the invasion of pituitary adenoma
Huachun Yin, Xiaoshuang Tang, Yi Peng, et al.
Journal of Endocrinological Investigation (2024) Vol. 48, Iss. 2, pp. 317-332
Closed Access | Times Cited: 4

Advances in autonomic dysfunction research in Parkinson’s disease
Huichun Xu, Xiaolei Zheng, Xinyue Xing, et al.
Frontiers in Aging Neuroscience (2025) Vol. 17
Open Access

Study on the Modulation of NLRP1 by Natural Products in Neurodegenerative Diseases
Tingting Wang, Xintong Zuo, Ling Cheng, et al.
Natural Product Communications (2025) Vol. 20, Iss. 3
Open Access

Page 1 - Next Page

Scroll to top